| Literature DB >> 16568892 |
Nils Loewen1, Eric M Poeschla.
Abstract
We review the use of lentiviral vectors in current human gene therapy applications that involve genetic modification of nondividing tissues with integrated transgenes. Safety issues, including insertional mutagenesis and replication-competent retroviruses, are discussed. Innate cellular defenses against retroviruses and their implications for human gene therapy with different lentiviral vectors are also addressed.Entities:
Mesh:
Year: 2005 PMID: 16568892 DOI: 10.1007/10_007
Source DB: PubMed Journal: Adv Biochem Eng Biotechnol ISSN: 0724-6145 Impact factor: 2.635